This is a historical report — it no longer reflects this drug's current status. Current status: Anticipated Shortage. View this drug's full profile page →
CIPRO ORAL SUSPENSION
BAYER INC
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of CIPRO ORAL SUSPENSION in Canada?
A shortage of CIPRO ORAL SUSPENSION 500MG is expected: the manufacturer reported it to Health Canada as an anticipated shortage (last updated September 18, 2026), but it has not started yet.
When will CIPRO ORAL SUSPENSION be available again?
The manufacturer's estimated resolution date is March 1, 2027. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean the shortage is completely over everywhere?
It means this specific report has been marked resolved or was avoided — but some individual pharmacies may still take time to restock.
What should I do?
If your pharmacy still doesn't have it, check with them directly — supply is expected to be normalizing.
DIN
02237514
Strength
500MG
Dosage Form
SUSPENSION
Route
ORAL
Active Ingredient
CIPROFLOXACIN
Tier
Unrated
Last Updated
2023-03-06
Reason for Shortage
Other (Please describe in comments)
Past Reports for This Drug
CIPRO ORAL SUSPENSION has 2 shortage/discontinuation reports on file — this is one of them.
Other Products from BAYER INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
60MG · DIN 02155990
20MG · DIN 02237618
30MG · DIN 02155907
0.5MG · DIN 02412764
2MG · DIN 02412802
2.5MG · DIN 02412810
1MG · DIN 02412772
1.5MG · DIN 02412799
5MG · DIN 02243919
0.5MG · DIN 02247193
DIN 02309300
220MG · DIN 02436337